You and others are overreacting to the correction
Post# of 148184
(Total Views: 471)
Posted On: 03/16/2020 9:15:16 AM
Re: Cytodynamite #21689
You and others are overreacting to the correction to last week’s PR. Here is what the PR said about the correction to last week:
“Patient #1 had missed one treatment of carboplatin and will continue to be treated with carboplatin and leronlimab.“
We don’t know where the mistake in communication occurred. Did the patient and/or doctor miscommunicate and was the correction given to CYDY after the PR? That’s what it appear happened to me.
The facts are clear: the the patient is improving on leronlimab and will continue with treatment in the trial. That’s all that matters.
You’re not fooling anyone by acting concerned about bashers.
“Patient #1 had missed one treatment of carboplatin and will continue to be treated with carboplatin and leronlimab.“
We don’t know where the mistake in communication occurred. Did the patient and/or doctor miscommunicate and was the correction given to CYDY after the PR? That’s what it appear happened to me.
The facts are clear: the the patient is improving on leronlimab and will continue with treatment in the trial. That’s all that matters.
You’re not fooling anyone by acting concerned about bashers.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼